Originally developed as a more-potent follow-up to Roche's long-established CD20-directed antibody Rituxan (rituximab) for ...

Phase 3 trials showed Vanrafia slowed the decline in kidney function for adults with the progressive autoimmune kidney ...

It’s déjà vu all over again. Just as the kidney disease space becomes increasingly competitive, Novartis has found itself intending to turn a statistical miss into a regulatory win. | It’s déjà vu all ...

The human kidney filters about a cup of blood every minute, removing waste, excess fluid, and toxins from it, while also ...

Fish treated with SGLT2 inhibitors maintained healthier kidneys as they aged. Their kidneys preserved denser networks of capillaries, retained a stronger filtration barrier, and showed more stable ...

Chronic kidney disease (CKD) affects nearly 36 million people. “CKD is a real public health crisis, and one that’s steadily rising,” said Merlin Thomas, M.B.Ch.B., Ph.D., FRACP, a professor of ...

Early kidney damage is silent but preventable routine blood and urine tests catch it before symptoms.

That vitamin bottle on your kitchen counter promising improved energy, stronger immunity, or enhanced performance might hide an uncomfortable truth – many popular supplements can damage your kidneys ...

BMI OrganBank®, a developer of integrated organ preservation and assessment systems, today announced the presentation of preclinical data evaluating its OrganBank Kidney® platform using its unique ...

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year, ...

Investing.com -- Novartis announced Friday that its drug Vanrafia has demonstrated effectiveness in slowing the decline of kidney function in adults with IgA nephropathy (IgAN), a progressive ...